Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Song-Yang Zhang has a total of 175 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Attenuation of TCA Cycle Enzyme Alpha-Ketoglutarate Dehydrogenase (KGDH) Activity Reveals it is an Important Hydrogen Peroxide (H2O2) Source in Human THP-1 Macrophages

    by Meijing Li, Darina Horescu, Audrey-Anne Bernier, Song-Yang Zhang, Luis Agellon, Ryan Mailloux

    Tricarboxylic acid (TCA) cycle enzyme alpha-ketoglutarate dehydrogenase (KGDH) has been identified as a potent source of hydrogen peroxide (H2O2) in several mammalian cell types. Since pro-inflammatory (M1) macrophage polarization is dependent on H2O2 signaling, we hypothesized KGDH-driven H2O2 was necessary for the polarization of naïve macrophages (M0) to the M1 phase. Utilizing differentiated human THP-1 monocytes, we demonstrate for the first time that KGDH activity is an obligate requirement for pro-inflammatory M1 macrophage polarization. Incubating THP-1 monocytes as well as M0 and M1 cells derived from the THP-1 monocytes in 2-keto-3-methylvaleric acid (KMV), a KGDH inhibitor, suppressed cell H2O2 production to same extent as ML171, a site-specific inhibitor for NOX1. By contrast S1QEL 1.1 (S1) and S3QEL 2 (S3), selective neutralizers of H2O2 production by complexes I and III, had a negligible effect on cell H2O2 generation. Our investigations into the impact of KMV on macrophage metabolism using the Seahorse XFe24 revealed that this metabolite promoted oxidative phosphorylation (OxPhos) in the cells differentiating to the M1 phase, suggesting inhibiting KGDH promotes M2 traits. This effect was associated with a decreased succinate/α-ketoglutarate ratio. qPCR analysis revealed KMV treatment decreased the expression of several pro-inflammatory genes such as NFκB, HIF-1α, TNFα, and IL-1β. Immunoblot showed KMV decreased phospho-p65 in cells undergoing differentiation to the M1 phase. siRNA knockdown of KGD (E1) subunit of KGDH attenuated cell H2O2 production, which was associated with the decreased mRNA abundance of NFκB, HIF-1α, TNFα, IL-1β, and GAPDH. In sum, our findings provide new insights into a previously unknown regulatory function of KGDH in macrophages.

  • Open Access

    GDF15: Anxiety Signalling From the Adipose Tissue

    by Song‐Yang Zhang


  • Open Access

    Pharmacological and physiological activation of TGR5 in the NTS lowers food intake by enhancing leptin-STAT3 signaling

    by Kyla Bruce, Song-Yang Zhang, Ameth N. Garrido, Melissa T. Wang, Tomás P. Bachor, Pengcheng Wang, Allison W. Xu, Zeyu Yang, Tony K. T. Lam

    Feeding increases plasma bile acid levels while the nucleus of the solitary tract (NTS) and area postrema (AP) of the brain detect changes in hormones to regulate feeding. However, whether an increase in bile acids activates Takeda G protein-coupled receptor 5 (TGR5) in the NTS and/or AP to lower feeding through a negative feedback pathway is unknown. Here, we discover that infusion of TGR5 agonist CCDC in the NTS of male rats lowered food intake without causing conditional taste avoidance in short-term high fat (HF) fed male rats in association with HF-induced increase in TGR5 expression in the NTS. In contrast, CCDC infusion into the AP failed to lower food intake in HF rats with a reduction in TGR5 expression in the AP. CCDC infusion in the NTS activates TGR5 to reverse HF-induced leptin resistance by enhancing a leptin-leptin receptor-STAT3 signaling axis selectively in the NTS to lower feeding. Finally, metabolomic analysis indicated that HF impaired a refeeding-induced rise of endogenous TGR5 ligand deoxycholic acid in the plasma and subsequently in the NTS in association with hyperphagia, while direct infusion of deoxycholic acid in the NTS of HF rats activated TGR5 to lower feeding and enhanced leptin-STAT3 signaling, thereby altogether demonstrating physiological and pharmacological activation of TGR5 in the NTS regulates food intake. In summary, we discover that an activation of TGR5 in the NTS enhances leptin-STAT3 signaling to lower food intake. Our findings highlight the potential of targeting TGR5 to reverse leptin resistance in the NTS.


  • Erratum to “Adipose ADM2 ameliorates NAFLD via promotion of ceramide catabolism” [Acta Pharm Sin B 14 (2024) 4883–4898]

    by Pengcheng Wang, Song-Yang Zhang, YongQiang Dong, Guangyi Zeng, Huiying Liu, Xian Wang, Changtao Jiang, Yin Li


  • Open Access

    Adipose ADM2 ameliorates NAFLD via promotion of ceramide catabolism

    by Pengcheng Wang, Song-Yang Zhang, YongQiang Dong, Guangyi Zeng, Huiying Liu, Xian Wang, Changtao Jiang, Yin Li


  • Open Access

    Regulation of Energy and Glucose Homeostasis by the Nucleus of the Solitary Tract and the Area Postrema

    by Kyla Bruce, Ameth N. Garrido, Song-Yang Zhang, Tony K.T. Lam

    The central nervous system regulates feeding, weight and glucose homeostasis in rodents and humans, but the site-specific mechanisms remain unclear. The dorsal vagal complex in the brainstem that contains the nucleus of the solitary tract (NTS) and area postrema (AP) emerges as a regulatory center that impacts energy and glucose balance by monitoring hormonal and nutrient changes. However, the specific mechanistic metabolic roles of the NTS and AP remain elusive. This mini-review highlights methods to study their distinct roles and recent findings on their metabolic differences and similarities of growth differentiation factor 15 (GDF15) action and glucose sensing in the NTS and AP. In summary, future research aims to characterize hormonal and glucose sensing mechanisms in the AP and/or NTS carries potential to unveil novel targets that lower weight and glucose levels in obesity and diabetes.


  • Open Access

    The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21

    by Suowen Xu, Zhenghong Liu, Tian Tian, Wenqi Zhao, Zhihua Wang, Monan Liu, Mengyun Xu, Fanshun Zhang, Zhidan Zhang, Meijie Chen, et al.

    Obesity is a debilitating disease with increasing worldwide prevalence. Despite its high prevalence, specific pharmacologic intervention for obesity is challenging. Here, we report that halofuginone, an FDA-approved anti-scleroderma and anti-protozoal drug, is a promising anti-obesity agent in rodent models. Halofuginone suppressed food intake, increased energy expenditure, and resulted in weight loss in preclinical diet-induced obese mouse models, while also decreasing insulin resistance and hepatic steatosis. By combining genetic and pharmacological tools with transcriptomics, we identified that halofuginone increases FGF21 and GDF15 levels via ATF4. Using knockout mice, we show these hormones are both necessary for its anti-obesity effects. Thus, our study first reports the beneficial metabolic effects of halofuginone and underscores its utility to treat obesity and its associated metabolic complications.

  • Small intestinal CaSR-dependent and CaSR-independent protein sensing regulates feeding and glucose tolerance in rats

    by Rosa J. W. Li, Daniel R. Barros, Rachel Kuah, Yu-Mi Lim, Anna Gao, Jacqueline L. Beaudry, Song-Yang Zhang, Tony K. T. Lam

    Proteins activate small intestinal calcium sensing receptor (CaSR) and/or peptide transporter 1 (PepT1) to increase hormone secretion1,2,3,4,5,6,7,8, but the effect of small intestinal protein sensing and the mechanistic potential of CaSR and/or PepT1 in feeding and glucose regulation remain inconclusive. Here we show that, in male rats, CaSR in the upper small intestine is required for casein infusion to increase glucose tolerance and GLP1 and GIP secretion, which was also dependent on PepT1 (ref. 9). PepT1, but not CaSR, is required for casein infusion to lower feeding. Upper small intestine casein sensing fails to regulate feeding, but not glucose tolerance, in high-fat-fed rats with decreased PepT1 but increased CaSR expression. In the ileum, a CaSR-dependent but PepT1-independent pathway is required for casein infusion to lower feeding and increase glucose tolerance in chow-fed rats, in parallel with increased PYY and GLP1 release, respectively. High fat decreases ileal CaSR expression and disrupts casein sensing on feeding but not on glucose control, suggesting an ileal CaSR-independent, glucose-regulatory pathway. In summary, we discover small intestinal CaSR- and PepT1-dependent and -independent protein sensing mechanisms that regulate gut hormone release, feeding and glucose tolerance. Our findings highlight the potential of targeting small intestinal CaSR and/or PepT1 to regulate feeding and glucose tolerance.


  • Acute Activation of GFRAL in the Area Postrema Contributes to Glucose Regulation Independent of Weight

    by Song-Yang Zhang, Zahra Danaei, Kyla Bruce, Jennifer F.M. Chiu, Tony K.T. Lam

    GDF15 regulates energy balance and glucose homeostasis in rodents by activating its receptor GFRAL, expressed in the area postrema of the brain. However, whether GDF15-GFRAL signaling in the area postrema regulates glucose tolerance independent of changes in food intake and weight and contributes to the glucose-lowering effect of metformin remain unknown. Herein, we report that direct, acute GDF15 infusion into the area postrema of rats fed a high-fat diet increased intravenous glucose tolerance and insulin sensitivity to lower hepatic glucose production independent of changes in food intake, weight, and plasma insulin levels under conscious, unrestrained, and nonstressed conditions. In parallel, metformin infusion concurrently increased plasma GDF15 levels and glucose tolerance. Finally, a knockdown of GFRAL expression in the area postrema negated administration of GDF15, as well as metformin, to increase glucose tolerance independent of changes in food intake, weight, and plasma insulin levels. In summary, activation of GFRAL in the area postrema contributes to glucose regulation of GDF15 and metformin in vivo. Article Highlights:


  • Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight

    by Song-Yang Zhang, Kyla Bruce, Zahra Danaei, Rosa J.W. Li, Daniel R. Barros, Rachel Kuah, Yu-Mi Lim, Laura H. Mariani, David Z. Cherney, Jennifer F.M. Chiu, et al.